Today In Healthcare: Gilead Sciences (GILD), MannKind Corporation (MNKD), Ariad Pharmaceuticals (ARIA), Nymox Pharmaceutical (NYMX)

Gilead Sciences Climbs On Positive Earnings Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences seems to be today’s biggest story in the healthcare space. While several investors were concerned about the company’s ability to continue to produce earnings growth, those concerns were put to rest last night when the company’s earnings report for the quarter was … Read more

Biotech Beat: Pfizer (PFE), Nymox Pharmaceutical Corporation (NYMX), Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Cytori Therapeutics (CYTX)

Pfizer Gains On Positive Earnings & Updated Guidance Pfizer (NYSE: PFE) Pfizer released their earnings report for the second quarter today. The report was overwhelmingly positive. While PFE did miss top-line expectations, when it comes to earnings, they beat analyst expectations by $0.04 per share. As a matter of fact, the quarter’s performance was so … Read more